Spyridon Papapetropoulos is Chief Medical Officer of Vigil Neuroscience, Inc.. Currently has a direct ownership of 4,000 shares of VIGL, which is worth approximately $12,080. The most recent transaction as insider was on Nov 18, 2022, when has been sold 300 shares (Common Stock) at a price of $14.0 per share, resulting in proceeds of $4,200. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4K
0% 3M change
0% 12M change
Total Value Held $12,080

Spyridon Papapetropoulos Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 18 2022
SELL
Open market or private sale
$4,200 $14.0 p/Share
300 Reduced 6.98%
4,000 Common Stock
Nov 18 2022
BUY
Exercise of conversion of derivative security
$567 $1.89 p/Share
300 Added 6.52%
4,300 Common Stock
May 03 2022
BUY
Open market or private purchase
$13,600 $3.4 p/Share
4,000 Added 50.0%
4,000 Common Stock

Also insider at

LPCN
Lipocine Inc. Healthcare
SP

Spyridon Papapetropoulos

Chief Medical Officer
Cambridge, MA

Track Institutional and Insider Activities on VIGL

Follow Vigil Neuroscience, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VIGL shares.

Notify only if

Insider Trading

Get notified when an Vigil Neuroscience, Inc. insider buys or sells VIGL shares.

Notify only if

News

Receive news related to Vigil Neuroscience, Inc.

Track Activities on VIGL